NCI Licenses Ariadne’s Pathway, Microarray Analysis Software | GenomeWeb
NEW YORK (GenomeWeb News) – Ariadne Genomics said today that the National Cancer Institute has licensed its Pathway Studio and PathwayExpert software.
 
The NCI has purchased site licenses of the pathway analysis software as well as its ResNet database, making the software available to every NCI researcher, Ariadne said. NCI will use the software packages for pathway and microarray data analysis with integrated literature mining, the company said.
 

Financial terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.